Pia R. Kamstrup

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.

Journal: Circulation
Published: August 30, 2026

Lp(a) testing and treatment with Lp(a)-lowering therapies in the primary and secondary prevention of cardiovascular disease in high income countries: A preliminary health technology assessment.

Lp(a) testing and treatment with Lp(a)-lowering therapies in the primary and secondary prevention of cardiovascular disease in high income countries: A preliminary health technology assessment.

Journal: Atherosclerosis
Published: July 02, 2026

High Lipoprotein(a) in Cardiovascular Disease: Measure Early and Act Early.

High Lipoprotein(a) in Cardiovascular Disease: Measure Early and Act Early.

Journal: JACC. Case reports
Published: April 01, 2026

Editorial: High lipoprotein(a) - a lifelong risk factor and mortality predictor.

Editorial: High lipoprotein(a) - a lifelong risk factor and mortality predictor.

Journal: European journal of preventive cardiology
Published: March 11, 2026

High Lipoprotein(a) and Valvular and Cardiovascular Events in Patients With Aortic Stenosis: A Meta-Analysis.

High Lipoprotein(a) and Valvular and Cardiovascular Events in Patients With Aortic Stenosis: A Meta-Analysis.

Journal: JACC. Advances
Published: January 29, 2026

Risk Stratified Breast Cancer Screening: Early Outcomes and Psychological Impact from PRSONAL - a Randomized Clinical Trial.

Risk Stratified Breast Cancer Screening: Early Outcomes and Psychological Impact from PRSONAL - a Randomized Clinical Trial.

Journal: Breast (Edinburgh, Scotland)
Published: November 21, 2025

High lipoprotein(a) and high BMI jointly confer the highest risk of ASCVD in both primary and secondary prevention.

High lipoprotein(a) and high BMI jointly confer the highest risk of ASCVD in both primary and secondary prevention.

Journal: European journal of preventive cardiology
Published: October 29, 2025

Risk-stratified breast cancer screening - a protocol for a non-blinded randomised trial.

Risk-stratified breast cancer screening - a protocol for a non-blinded randomised trial.

Journal: Danish medical journal
Published: October 24, 2025

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency.

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency.

Journal: Cardiovascular research
Published: October 13, 2025

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency.

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency.

Journal: Cardiovascular research
Published: October 13, 2025

Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis.

Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis.

Journal: Atherosclerosis
Published: July 04, 2025

Response by Kristensen et al to Letter Regarding Article, "Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans".

Response by Kristensen et al to Letter Regarding Article, "Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans".

Journal: Circulation
Published: May 27, 2025
Showing 1-12 of 95

Last Updated: 09/26/2026